MSON Profile
MISONIX,
Inc. (MSON) is a medical device company that develops and sells
ultrasonic surgical devices. These devices use high-frequency sound
waves to remove or manipulate tissue during surgical procedures. The
company's products are used in a variety of surgical specialties,
including neurosurgery, orthopedics, and plastic surgery.
MISONIX's flagship product is the BoneScalpel, which is used to remove
bone during surgery. This device uses ultrasonic energy to make
precise cuts in bone, which reduces the risk of damage to surrounding
tissue. The BoneScalpel is used in spinal surgery, neurosurgery, and
orthopedic surgery, among other specialties.
In addition to the
BoneScalpel, MISONIX also sells a range of other ultrasonic surgical
devices. These include the SonaStar, which is used for soft tissue
removal, and the SonicOne, which is used for wound debridement and
soft tissue preservation.
MISONIX sells its products in the
United States and internationally. The company has distribution
agreements with a number of medical device distributors and also sells
its products directly to hospitals and surgeons.
MISONIX was
founded in 1959 and is headquartered in Farmingdale, New York. The
company is publicly traded on the NASDAQ stock exchange under the
ticker s
|
